Inactive Instrument

Heat Biologics Inc Stock Nasdaq

Equities

US42237K1025

Pharmaceuticals

Sales 2024 * 20.6M Sales 2025 * 35.1M Capitalization 6.09M
Net income 2024 * -22M Net income 2025 * -16M EV / Sales 2024 * 0.3 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.17 x
P/E ratio 2024 *
-0.27 x
P/E ratio 2025 *
-0.37 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.69%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 08-06-09
Director of Finance/CFO 56 19-09-24
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 16-04-25
Chief Executive Officer 60 08-06-09
Director/Board Member 48 08-12-31
More insiders
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
More about the company